Vincents Riverside is actively conducting a clinical trial that aims to provide a long-term solution for weight maintenance through a novel outpatient endoscopic procedure that targets the lining of the small intestine
SUMMARY With the recent completion of large, prospective, double-blind, placebo-controlled cardiovascular outcome studies, we have moved into a new era of diabetes treatment in which antidiabetic medications that both reduce glycemia, thereby preventing microvascular complications, and prevent macrovascular complications (MI, stroke, CV mortality) should be considered as first line therapy for the treatment of T2DM patients at high cardiovascular risk
Changes may be coming The FDA, under Kennedys authority, recently removed a number of experts from the compounding advisory panel
Patients should consult a licensed healthcare provider before starting any wellness or peptide therapy program.
IV Glutathione and Diabetes Mellitus
That's what Phase 3 trials are designed to assess